0001641241-16-000002.txt : 20160406 0001641241-16-000002.hdr.sgml : 20160406 20160405175804 ACCESSION NUMBER: 0001641241-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160406 DATE AS OF CHANGE: 20160405 EFFECTIVENESS DATE: 20160406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyrus Biotechnology, Inc. CENTRAL INDEX KEY: 0001641241 IRS NUMBER: 471015686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-260713 FILM NUMBER: 161555844 BUSINESS ADDRESS: STREET 1: 1201 BOYLSTON AVE. STREET 2: UNIT 417 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 6178182334 MAIL ADDRESS: STREET 1: 1201 BOYLSTON AVE. STREET 2: UNIT 417 CITY: SEATTLE STATE: WA ZIP: 98101 D 1 primary_doc.xml X0707 D LIVE 0001641241 Cyrus Biotechnology, Inc. 1201 BOYLSTON AVE. UNIT 417 SEATTLE WA WASHINGTON 98101 206-258-6561 DELAWARE None None Corporation true 2014 Lucas Nivon 500 Yale Ave N Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Yifan Song 500 Yale Ave N Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Javier Castellanos 500 Yale Ave N Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false 2016-03-23 false true true Debt is convertible, under certain cicumstances, into issuer equity. false 0 575000 535000 40000 false 14 0 0 0 false Cyrus Biotechnology, Inc. /s/ Lucas Nivon Lucas Nivon CEO 2016-04-05